Flibanserin for Treating Hypoactive Sexual Desire Disorder
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
There have been several products developed for male sexual dysfunction. However, developing agents for female sexual dysfunction is lagging behind for various reasons. Sildenafil citrate (Viagra) and Tadalafil (Cialis), which have been prescribed for male sexual function disorders, are known to act on vessels.[1] On the other hand, flibanserin is thought to act on brain. Flibanserin has been approved by U. S. Food and Drug Administration (FDA) for treatment of hypoactive sexual desire disorder (HSDD) of premenopausal women in 2015, and is expected to be released in South Korea soon. Authors wrote this article to acknowledge flibanserin to sexologists for females or physicians for menopausal medicine, so that this agent can be safely used for females who have HSDD. (J Menopausal Med 2016;22:9-13)
Abstract
There have been several products developed for male sexual dysfunction. However, developing agents for female sexual dysfunction is lagging behind for various reasons. Sildenafil citrate (Viagra) and Tadalafil (Cialis), which have been prescribed for male sexual function disorders, are known to act on vessels.[1] On the other hand, flibanserin is thought to act on brain. Flibanserin has been approved by U. S. Food and Drug Administration (FDA) for treatment of hypoactive sexual desire disorder (HSDD) of premenopausal women in 2015, and is expected to be released in South Korea soon. Authors wrote this article to acknowledge flibanserin to sexologists for females or physicians for menopausal medicine, so that this agent can be safely used for females who have HSDD. (J Menopausal Med 2016;22:9-13)
참고문헌 (16)
- 김미진, "G-protein Coupled Estrogen Receptor (GPER", GPR30) and Women’s Health, 2015, pp.21(2), 79~81[DOI]
- Kang BM, "Menopausal symptoms and comwplementary and alternative therapy", J Korean Soc Menopause, 13, pp.164~172 (2007)
- Borsini F, "Pharmacology of flibanserin", CNS Drug Rev, 8, pp.117~142 (2002)
- Kennedy S, "Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder", J Sex Med, 7, pp.3449~3459 (2010)
- American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (2000), American Psychiatric Association
- Derogatis LR, "Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET study", J Sex Med, 9, pp.1074~1085 (2012)
- Thorp J, "Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study", J Sex Med, 9, pp.793~804 (2012)
- Katz M, "Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial", J Sex Med, 10, pp.1807~1815 (2013)
- "FDA briefing document: Joint meeting of the bone, reproductive and urologic drugs advisory committee (BRUDAC) and the drug safety and risk management (DSaRM) advisory committee" (2015)[URL]
- "‘Viagra for Women’ gets push for F.D.A. approval" (2015)[URL]
- "Aid to women, or bottom line? Advocates split on libido pill" (2015)[URL]
- Gnanasakthy A, "A review of patient-reported outcome labels in the United States: 2006 to 2010", Value Health, 15, pp.437~442 (2012)
- Derogatis L, "Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder", J Sex Med, 5, pp.357~364 (2008)
- 곽은경, "Menopause Knowledge, Attitude, Symptom and Management among Midlife Employed Women", 대한폐경학회지, 20(3), pp.118~125 (2014), 대한폐경학회
- Hyunkyung Kim, "The Recent Review of the Genitourinary Syndrome of Menopause", 대한폐경학회지, 21(2), pp.65~71 (2015), 대한폐경학회
- 김성민, "유니센타주와 멜스몬주의 폐경증상 개선에 대한 효과와 안전성 비교평가", 대한폐경학회지, 19(1), pp.36~44 (2013), 대한폐경학회